Skydeck Capital

Overview

Skydeck Capital is a private investment firm investing capital on behalf of the Polsky family. The firm targets direct investments in lower-middle market companies, real estate, and venture capital. With a proprietary capital base, Skydeck Capital is not bound by predefined time horizons or investment hurdles, allowing it to focus on long-term impact and value creation. Established in 2013, Skydeck Capital is headquartered in Chicago, Illinois. The firm invests across various sectors, including technology, consumer products, healthcare, industrial, B2B services, manufacturing, and engineered industrial products. It also makes real estate investments in value-add commercial or multi-family properties, sale-leasebacks, and covered land plays. Skydeck Capital's investment approach is flexible and evergreen, supporting sustainable growth in its portfolio companies. The firm typically makes equity investments ranging from $5 million to $10 million, seeking well-located industrial, multi-family, and office assets with experienced sponsors and operators who are willing to invest alongside Skydeck Capital. The firm's portfolio includes companies such as Grove Biopharma, Avant, CancerIQ, Sunbit, Built In, Vambe, and YourSix.